ID

38801

Beschreibung

Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT01947855

Link

https://clinicaltrials.gov/show/NCT01947855

Stichworte

Versionen (1)
  1. 05.11.19 05.11.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

5. November 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes Mellitus, Type 2 NCT01947855

Englisch

Eligibility Diabetes Mellitus, Type 2 NCT01947855

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of type 2 diabetes mellitus prior to informed consent
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
male and female patients on diet and exercise regimen for 12 weeks prior to informed consent who are:
Beschreibung

Gender | Diet therapy | Exercise

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0012159
UMLS CUI [3]
C0015259
drug-naïve, defined as no antidiabetic drugs for at least 12 weeks prior to informed consent or,
Beschreibung

Pharmaceutical Preparations Absent | Antidiabetics Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C0332197
pre-treated with one oral antidiabetic drug (except sulfonylurea and thiazolidinedione); the present antidiabetic therapy has to be unchanged for at least 12 weeks prior to the informed consent. (sulfonylurea is permitted as pre-treatment drug only if the dose is equal or less than a half of daily maximum approval dose.)
Beschreibung

Pretreatment | Antidiabetics Oral Quantity | Exception Sulfonylurea | Exception Thiazolidinediones | Diabetes Therapy unchanged

Datentyp

boolean

Alias
UMLS CUI [1]
C3539076
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C1265611
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0038766
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1257987
UMLS CUI [5,1]
C3274787
UMLS CUI [5,2]
C0442739
glycosylated haemoglobin (hba1c) at visit 1 (screening)
Beschreibung

HbA1c

Datentyp

boolean

Alias
UMLS CUI [1]
C0019018
for patients without antidiabetic therapy : hba1c >=7.0 to =<10.0%
Beschreibung

Diabetes Therapy Absent | Hemoglobin A1c measurement

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3274787
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0474680
for patients with one oral antidiabetic drug : hba1c >=7.0 to =<9.5%
Beschreibung

Antidiabetics Oral Quantity | Hemoglobin A1c measurement

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C1265611
UMLS CUI [2]
C0474680
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
uncontrolled hyperglycaemia with a glucose level >240 mg/dl (>13.3 mmol/l)
Beschreibung

Hyperglycemia Uncontrolled | Glucose level

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020456
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0428548
impaired renal function, defined as estimated glomerular filtration rate (egfr) <60 ml/min/1.73m2 (moderate and severe renal impairment, modification of diet in renal disease (mdrd) formula)
Beschreibung

Renal Insufficiency | Estimated Glomerular Filtration Rate | Renal Insufficiency Moderate MDRD formula | Renal Insufficiency Severe MDRD formula

Datentyp

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C3811844
UMLS CUI [3,1]
C1565489
UMLS CUI [3,2]
C0205081
UMLS CUI [3,3]
C3839656
UMLS CUI [4,1]
C1565489
UMLS CUI [4,2]
C0205082
UMLS CUI [4,3]
C3839656
acute coronary syndrome, stroke or transient ischemic attack (tia) within 12 weeks prior to informed consent
Beschreibung

Acute Coronary Syndrome | Cerebrovascular accident | Transient Ischemic Attack

Datentyp

boolean

Alias
UMLS CUI [1]
C0948089
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0007787
indication of liver disease, defined by serum levels of either alanine transaminase (alt), aspartate transaminase (ast), or alkaline phosphatase (alp) above 3 x upper limit of normal (uln)
Beschreibung

Indication Liver disease | Alanine aminotransferase increased | Aspartate aminotransferase increased | Serum alkaline phosphatase raised

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0023895
UMLS CUI [2]
C0151905
UMLS CUI [3]
C0151904
UMLS CUI [4]
C1314665
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Diabetes Mellitus, Type 2 NCT01947855

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
diagnosis of type 2 diabetes mellitus prior to informed consent
boolean
C0011860 (UMLS CUI [1])
Gender | Diet therapy | Exercise
Item
male and female patients on diet and exercise regimen for 12 weeks prior to informed consent who are:
boolean
C0079399 (UMLS CUI [1])
C0012159 (UMLS CUI [2])
C0015259 (UMLS CUI [3])
Pharmaceutical Preparations Absent | Antidiabetics Absent
Item
drug-naïve, defined as no antidiabetic drugs for at least 12 weeks prior to informed consent or,
boolean
C0013227 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0935929 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Pretreatment | Antidiabetics Oral Quantity | Exception Sulfonylurea | Exception Thiazolidinediones | Diabetes Therapy unchanged
Item
pre-treated with one oral antidiabetic drug (except sulfonylurea and thiazolidinedione); the present antidiabetic therapy has to be unchanged for at least 12 weeks prior to the informed consent. (sulfonylurea is permitted as pre-treatment drug only if the dose is equal or less than a half of daily maximum approval dose.)
boolean
C3539076 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0038766 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C1257987 (UMLS CUI [4,2])
C3274787 (UMLS CUI [5,1])
C0442739 (UMLS CUI [5,2])
HbA1c
Item
glycosylated haemoglobin (hba1c) at visit 1 (screening)
boolean
C0019018 (UMLS CUI [1])
Diabetes Therapy Absent | Hemoglobin A1c measurement
Item
for patients without antidiabetic therapy : hba1c >=7.0 to =<10.0%
boolean
C3274787 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0474680 (UMLS CUI [2])
Antidiabetics Oral Quantity | Hemoglobin A1c measurement
Item
for patients with one oral antidiabetic drug : hba1c >=7.0 to =<9.5%
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0474680 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Hyperglycemia Uncontrolled | Glucose level
Item
uncontrolled hyperglycaemia with a glucose level >240 mg/dl (>13.3 mmol/l)
boolean
C0020456 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0428548 (UMLS CUI [2])
Renal Insufficiency | Estimated Glomerular Filtration Rate | Renal Insufficiency Moderate MDRD formula | Renal Insufficiency Severe MDRD formula
Item
impaired renal function, defined as estimated glomerular filtration rate (egfr) <60 ml/min/1.73m2 (moderate and severe renal impairment, modification of diet in renal disease (mdrd) formula)
boolean
C1565489 (UMLS CUI [1])
C3811844 (UMLS CUI [2])
C1565489 (UMLS CUI [3,1])
C0205081 (UMLS CUI [3,2])
C3839656 (UMLS CUI [3,3])
C1565489 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C3839656 (UMLS CUI [4,3])
Acute Coronary Syndrome | Cerebrovascular accident | Transient Ischemic Attack
Item
acute coronary syndrome, stroke or transient ischemic attack (tia) within 12 weeks prior to informed consent
boolean
C0948089 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
Indication Liver disease | Alanine aminotransferase increased | Aspartate aminotransferase increased | Serum alkaline phosphatase raised
Item
indication of liver disease, defined by serum levels of either alanine transaminase (alt), aspartate transaminase (ast), or alkaline phosphatase (alp) above 3 x upper limit of normal (uln)
boolean
C3146298 (UMLS CUI [1,1])
C0023895 (UMLS CUI [1,2])
C0151905 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C1314665 (UMLS CUI [4])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video